TheraVet SA announced the appointment of Veerle Zonnekeyn as Director of Regulatory Affairs for TheraVet. She will be responsible for preparing the marketing authorization application for VISCO-VET in osteoarthritis in dogs in Europe and the United States. With this appointment, TheraVet strengthens its regulatory expertise in the veterinary field and more particularly in companion animals. Prior to joining TheraVet, Veerle Zonnekeyn was Director of Regulatory Affairs at Elanco, the world's 2nd largest animal health company, where she led the teams dedicated to the submission and approval of veterinary products by the European Medicines Agency.